208 results about "Food intake" patented technology

The invention relates to the field of biological medicine, in particular to application of hispidulin in preparation of a lipid de novo synthesis inhibitor or a metabolism-related fatty liver disease treatment or prevention product. The hispidulin disclosed by the invention has a chemical structure as shown in a formula (I). The hispidulin in the invention reverses liver cell lipid droplet excessive infiltration induced by high-dose fructose in a dose-dependent manner; furthermore, the hispidulin dose-dependent ameliorating obesity signs in HFD-induced MAFLD model mice, including liver weight, body weight, blood lipid level, liver fat content, and insulin resistance, without significantly reducing food intake.

The invention provides a captive panda oestrus starting prediction method and system based on machine learning, and relates to the technical field of panda breeding, and the method comprises the steps: obtaining original data; isomerous data stream synchronization is carried out according to the original data, and a synchronized spatio-temporal data matrix is obtained; performing nonlinear interaction relation modeling according to the synchronized spatio-temporal data matrix to construct a spatio-temporal dependency relation graph; performing environment constraint feature dimension reduction according to the space-time dependency graph to obtain a low-dimensional state representation vector; performing oestrus state transition probability calculation according to the low-dimensional state representation vector to generate a probability evolution trajectory; and according to the probability evolution trajectory, turning point identification is carried out, and an estrus starting moment prediction value is output. Through collaborative inflection point detection of progesterone gradient characteristics and an ingestion mutation mode in the probability evolution trajectory, an estrus starting moment prediction value is accurately output, and finally the biological interpretability of estrus critical state evolution of captive pandas is improved.

The invention discloses a composite microbial preparation for treating obesity of pet dogs and application of the composite microbial preparation, and belongs to the technical field of microbial preparations. The compound microbial preparation is prepared by fermenting lactobacillus acidophilus L100 and lactobacillus reuteri GBW1146, and the preservation number of the lactobacillus reuteri GBW1146 is CGMCC (China General Microbiological Culture Collection Center) No. 34455. The compound microbial preparation is prepared by fermenting lactobacillus acidophilus L100 and lactobacillus reuteri GBW1146. The compound microbial preparation can remarkably reduce digestion and absorption of intestinal tracts of dogs on fat and reduce triglyceride and cholesterol levels in blood, so that the average food intake and average calorie consumption of the dogs are reduced, and finally the effect of reducing obesity of the pets is achieved. The compound microbial preparation provided by the invention enhances the competitiveness of the pet feed additive and series products thereof in China in the international market, and has a wide application prospect.

The invention provides novel compounds which are peptide hormone analogues, and which are useful in treating disorders such as diabetes and obesity. The compounds of the general sequence recited in the specification possess a tailored profile with regards to potency properties at the GIP receptor. With regard to in vivo properties, administration of example peptides of the invention have been shown, in animal models, to result in increased weight loss. Preferred compounds achieve this without reducing food intake significantly.

The present invention discloses a pet feeding device and a recognition system for pet feeding device, comprising: a housing, a hatch door arranged on the housing, and a food tray arranged in the housing, wherein the food tray can prevent pets from spilling food outside the food tray during eating. The housing is provided with a driving mechanism and a hatch door linkage mechanism, wherein the hatch door linkage mechanism is drivingly connected to an output end of the driving mechanism and connected with the hatch door. The driving mechanism is used for driving the hatch door linkage mechanism to lead the hatch door to open and close. This solution not only controls the food intake of the pets, but also controls the feeding time of the pets.

The invention relates to the technical field of food nutrition and health care and biological medicines, in particular to application of beta-1, 3 / alpha-1, 3-glucan in preparation of medicines for treating and / or preventing obesity and / or body weight super-severe illness and digestion-aiding health food. According to the experimental results, high-glucose and high-fat rats are continuously fed in the stomach for 8 weeks, and the food intake can be effectively reduced and the body weight can be reduced through preventive administration; the conclusion that beta-1, 3 / alpha-1, 3-glucan has the digestion-aiding health-care food function can be obtained according to the requirements of'health-care food function inspection and evaluation method (2023 edition) by combining the research results that beta-1, 3 / alpha-1, 3-glucan has the stimulation effect on small intestine peristalsis, promotes the growth of intestinal beneficial bacteria and regulates intestinal health in the existing research. The invention provides a new direction for preparing the medicine for treating and / or preventing obesity and / or body weight super-severe illness and health-care food beneficial to digestion.

The invention discloses weight-reducing and blood-sugar-reducing meal replacement powder for increasing satiety and a preparation method thereof, and belongs to the technical field of meal replacement powder. Comprising resistant starch, bio-enzyme modified whey protein concentrate, bio-enzyme modified soybean protein isolate, bio-enzyme modified white kidney bean hydrolyzed protein, oat fiber powder, nano emulsion milk powder, mogroside, chitosan, inulin, konjac powder, pumpkin seed powder, a cactus extract, a griffonia simplicifolia seed extract and a Chinese waxgourd peel extract. Through the synergistic effect of multiple components and multiple processes, the obvious effects of satiety, weight loss and blood sugar reduction are achieved. 5-hydroxytryptophan in the griffonia seed extract can regulate satiety center and delay hunger sensation; dietary fibers such as the resistant starch and the inulin absorb water and swell in intestinal tracts to form high-viscosity gel, so that the satiety is further enhanced, and the eating frequency and the eating amount are reduced. A low-calorie and high-protein formula is combined with components such as tartronic acid in the Chinese waxgourd peel extract and the cactus extract, so that fat catabolism is accelerated, and fat synthesis is inhibited.

Techniques disclosed herein relate generally to monitoring and tracking food intake events or other behaviors. In some examples, the techniques involve detecting, based on at least one of user input or sensor input from a first set of one or more sensors, a start of a food intake event; activating, in response to detecting the start of the food intake event, a second set of one or more sensors for tracking the food intake event; and determining, based on at least sensor data from the second set of one or more sensors, one or more event-specific parameters for the food intake event.

The invention discloses application of a traditional Chinese medicine composition in preparation of a product for resisting colon cancer and tumor hemagglutinin, and relates to the technical field of biology. The traditional Chinese medicine composition is prepared from the following components: 5-150 parts of American ginseng, 5-160 parts of lucid ganoderma, 1-90 parts of fermented cordyceps sinensis powder and 5-90 parts of roses. Or 5-150 parts of American ginseng, 5-160 parts of lucid ganoderma, 1-60 parts of cordyceps sinensis and 5-90 parts of rose. The traditional Chinese medicine composition provided by the invention can improve weight loss related to tumors, inhibit tumor growth, recover food intake, improve the athletic ability of a patient, relieve muscle and fat atrophy, inhibit spleen swelling, improve anemia and peripheral inflammation, and effectively relieve cancer-related fatigue caused by colon cancer, so that the traditional Chinese medicine composition provided by the invention has the advantages that the effect is obvious; the traditional Chinese medicine composition can be used for effectively treating colon cancer and malignant fluid, and has a wide application prospect in preparation of products for treating colon cancer and malignant fluid.

The invention discloses a diet intervention method and system for crowds with cardiopulmonary health risks. The system comprises a database, an information acquisition module, a risk assessment module, a calculation module, a diet recommendation module, an auditing module and an information pushing module. The database comprises a personal information database, a suggestion database, a recipe database and a different-energy-level food intake database; the information acquisition module is used for acquiring intelligent bed sleep health data and personal information data in a database, and generating a personal user data set for the risk assessment module and the calculation module; wherein the sleep health data collected by the intelligent bed comprises but is not limited to the whole late heart rate, the respiration rate, the heart rate variability and the like; according to the invention, through combination of static and dynamic health data, through risk assessment and early warning, diet health management is carried out on crowds with cardiopulmonary health risks, and the problem that the public cannot effectively utilize knowledge to carry out self-health management actually is accurately solved.

The invention relates to the field of health management, and discloses a comprehensive personalized nutrition management method, which comprises the following steps: acquiring multi-dimensional health data of a user through user side equipment, including gene information, living habits, exercise frequency and food intake information; analyzing the multi-dimensional health data by using an AI-driven health assessment model, and generating an assessment result of the health state of the user and potential risk factors; and generating a personalized diet plan by using a machine learning algorithm according to the health assessment result. Through multi-dimensional data acquisition and dynamic analysis, the health state of the user is comprehensively monitored, the diet plan is adjusted in real time, and the problem of insufficient static property in the prior art is solved; gene information and living habits are integrated, and a highly personalized effect is achieved; the diet recommendation accuracy is improved through data closed-loop optimization, and the defect that an existing scheme is insufficient in optimization capability is overcome; tLS encryption and distributed storage are adopted, data security is guaranteed, and user trust is enhanced.

A sensing device monitors and tracks food intake events and details. A processor, appropriately programmed, controls aspects of the sensing device to capture data, store data, analyze data and provide suitable feedback related to food intake. More generally, the methods might include detecting, identifying, analyzing, quantifying, tracking, processing and / or influencing, related to the intake of food, eating habits, eating patterns, and / or triggers for food intake events, eating habits, or eating patterns. Feedback might be targeted for influencing the intake of food, eating habits, or eating patterns, and / or triggers for those. The sensing device can also be used to track and provide feedback beyond food-related behaviors and more generally track behavior events, detect behavior event triggers and behavior event patterns and provide suitable feedback.

The invention discloses an FAM20B protein and application of an FAM20B protein inhibitor in prevention or treatment of glucolipid metabolism related diseases. Specifically, the invention discloses an application of an FAM20B protein and / or an FAM20B gene in regulation and control of liver glycolipid metabolism. The invention also discloses application of the FAM20B inhibitor in improving, preventing or treating liver glycolipid metabolism disorder or glycolipid metabolism related diseases (such as diabetes, metabolism related fatty liver disease MAFLD, obesity and the like). Experiments show that the FAM20B inhibitor can reduce the liver gluconeogenesis level, relieve impairment of glucose tolerance, relieve hyperglycemia of diabetic patients, reduce the fat content of the whole body and the liver, relieve liver lipid deposition, promote energy consumption, reduce food intake, promote fat burning and reduce liver fat accumulation; the compound can be used for preparing medicines for preventing and treating glucose and lipid metabolism disorder or glucose and lipid metabolism related diseases, and has a wide application prospect in the fields of prevention and treatment of metabolism related diseases.

The utility model relates to a mouse cage for managing drinking water and food of a mouse, which comprises a cage body, a cage cover, at least two weight sensors, a feeding assembly and a circuit board assembly, and the cage body is provided with a containing cavity which is used for containing the mouse and is provided with an upward opening; the cage cover covers the opening and is provided with at least two mounting ports, and the two mounting ports are arranged in a vertically through manner; the two weight sensors are installed on the lower end face of the cage cover, and at least parts of the two weight sensors are exposed out of the two corresponding installation openings. The feeding assembly comprises a water drinking structure and a stock bin, one end of the water drinking structure and one end of the stock bin are rotationally installed on the two installation openings respectively, the other end of the water drinking structure and the other end of the stock bin can be overturned vertically to open or close the corresponding installation openings, and when the corresponding installation openings are closed, the water drinking structure and the stock bin are in lap joint with the two weight sensors respectively; the circuit board assembly is installed on the cage cover and electrically connected with the two weight sensors. The food intake and water intake of the rats can be obtained through the weight change of the water drinking structure and the feed bin, and the rats are bred intelligently.

A system includes a processor that collects data representing activity levels, sleep patterns, and food intake from an information collection device attached to a dog, transmits the collected data to an analysis server, wherein the analysis server inputs the collected data into a generative artificial intelligence model and analyzes the data, transmits analysis results to a terminal and notifies a user, receives user input regarding questions or symptoms of the dog and generates advice using the generative artificial intelligence model, transmits the generated advice to the terminal for display to the user, and provides online consultation reservation with a veterinarian.

A sensing device monitors and tracks food intake events and details. A processor, appropriately programmed, controls aspects of the sensing device to capture data, store data, analyze data and provide suitable feedback related to food intake. More generally, the methods might include detecting, identifying, analyzing, quantifying, tracking, processing and / or influencing, related to the intake of food, eating habits, eating patterns, and / or triggers for food intake events, eating habits, or eating patterns. Feedback might be targeted for influencing the intake of food, eating habits, or eating patterns, and / or triggers for those. The sensing device can also be used to track and provide feedback beyond food-related behaviors and more generally track behavior events, detect behavior event triggers and behavior event patterns and provide suitable feedback.

The images related to this design are used, for example, to monitor, display, or track measurement data such as blood glucose levels, as well as exercise, insulin administration, and food intake. These images can be operated by tapping, pressing, swiping, or scrolling the display screen, or via other devices associated with the display device.

The invention relates to application of lactobacillus acidophilus LA85 in preparation of a product with a blood sugar reducing effect. The brand new application of the lactobacillus acidophilus LA85 strain is developed, namely the lactobacillus acidophilus LA85 strain is used for inhibiting alpha-glucosidase, reducing blood sugar and improving diabetes mellitus, and tests prove that the food intake, the water intake and the urine volume of a mouse with type II diabetes mellitus can be effectively controlled after intervention of the LA85 strain, and the weight value of the mouse is stabilized; the glucose absorption and metabolism capability of diabetic mice is effectively improved, and continuous damage of pancreatic beta cell functions is retarded; the blood lipid level disorder state of the mouse with the type II diabetes mellitus is improved; the inflammation level of a mouse body with type II diabetes mellitus is reduced, and the immunity is improved; and a very good improvement and recovery effect is achieved on abundance and diversity reduction of intestinal flora of the type II diabetes mellitus mice.

The present application relates to the technical field of food intake monitoring system, in particular to an intelligent energy cup food intake monitoring system and method thereof, a multi-sensor data acquisition module; a data preprocessing module electrically connected with the multi-sensor data acquisition module; an AI analysis module data connected with the data preprocessing module; according to the liquid type and the eating behavior, combined with the preset health standard, the real-time food intake of the user is calculated; based on the real-time food intake and the user historical data, the blood glucose curve of the user is predicted; an intelligent intervention module is signal connected with the AI analysis module, whether the preset health threshold is exceeded is judged; when the judgment result exceeds the health threshold, the corresponding intervention instruction is generated; a feedback execution module is control connected with the intelligent intervention module, a data storage and communication module is data connected with the multi-sensor data acquisition module, the AI analysis module and the intelligent intervention module respectively; the data is uploaded to the remote server through the wireless network, the cloud backup and analysis of the data are realized.

The invention relates to application of bifidobacterium animalis subsp. Lactis BLa80 in preparation of a preparation for assisting in improving diabetes mellitus. The bifidobacterium animalis subsp. Lactis BLa80 is a strain of the bifidobacterium animalis subsp. Lactis BLa80 with the preservation number of CGMCC (China General Microbiological Culture Collection Center) No.22547, and the strain of the bifidobacterium animalis subsp. Lactis BLa80 is a strain of the bifidobacterium animalis subsp. Lactis BLa80 with the preservation number of CGMCC No.22547. The brand new application of the BLa80 strain of the animal bifidobacterium subsp. Lactis is developed, that is, the BLa80 strain is used for improving diabetes, reducing blood sugar or inhibiting alpha-glucosidase, and tests prove that the BLa80 strain can effectively control the food intake, the water intake, the urine volume and the body weight of diabetic mice; the fasting blood-glucose value and the insulin resistance index of a diabetic mouse are reduced; the blood lipid level disorder state of diabetic mice can be improved; the inflammation level of a diabetic mouse body is reduced, anti-inflammatory factors of the mouse body are increased, and the immunity is improved; and the abundance and diversity of intestinal flora of diabetic mice can be improved and recovered.

The present invention provides an application of bradykinin in the preparation of a drug for reducing food intake, and a pharmaceutical composition, belonging to the technical field of biomedicine. The application of bradykinin or a pharmaceutically acceptable derivative thereof includes the application of bradykinin in the preparation of a drug for reducing food intake, and bradykinin has the amino acid sequence shown in SEQ ID No. 1. Bradykinin can inhibit food intake and reduce body weight through peripheral receptors rather than through the central nervous system; further, it can significantly reduce the food intake of mice and reduce the body weight of mice, which proves that bradykinin has the potential to treat obesity and can be used in the preparation of drugs for treating food intake inhibition or obesity. Moreover, bradykinin is an endogenous substance with high safety and relatively small side effects, and bradykinin acts on the peripheral system, avoiding the side effects of drugs acting on the central nervous system.

The present application relates to a kind of traditional Chinese medicine composition for treating pediatric anorexia, the traditional Chinese medicine composition is made of the following weight parts of raw medicinal materials: 7-11 parts of Taizishen, 7-11 parts of Cangzhu, 7-11 parts of Fuling, 7-11 parts of Huoxiang, 7-11 parts of Gegen, 7-11 parts of Qingpi, 6-13 parts of Laiqiezi, 4-8 parts of Lianqiao, 7-11 parts of Sanleng, 7-11 parts of Shanzha.The present application also provides the use of traditional Chinese medicine composition for pediatric anorexia.The present application uses several drugs together, which is integrated with invigorating spleen, transporting spleen and activating spleen, so that the spleen is healthy, the spleen and stomach qi movement is appropriate, and the human body qi movement is adjusted, so that the whole body qi movement is operated, the qi movement is operated, the five internal organs are harmonious, and the whole prescription plays the effect of invigorating spleen and transporting.The total effective rate and the improvement of TCM syndrome score of the traditional Chinese medicine composition of the present application are better than those of the control group, especially in improving the symptoms of anorexia, reduced food intake and other symptoms such as salivation, belching, hiccups, nausea and other symptoms.

Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing visceral fat in a mammal is provided where the composition comprises an effective amount of Cissus quadrangularis provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

The invention provides novel compounds which are peptide hormone analogues, and which are useful in treating disorders such as diabetes and obesity. The compounds of the general sequence recited in the specification possess a tailored profile with regards5 to potency properties at the GIP receptor. With regard to in vivo properties, administration of example peptides of the invention have been shown, in animal models, to result in increased weight loss. Preferred compounds achieve this without reducing food intake significantly.

The present invention discloses a long-acting GGG triple-target agonist. The compound of the present invention simultaneously achieves excellent agonist ability at the nM level for the three targets of GLP-1 / GIP / GCGR, and can fully excite the corresponding target organ tissue cells. The compound of the present invention can promote insulin secretion and lower blood sugar; it can also inhibit food intake, delay gastric emptying, increase energy consumption, and ultimately observe a weight loss effect. The compound of the present invention can reduce pancreatic β-cell apoptosis, increase the number of pancreatic β-cells, and improve pancreatic cell function. The compound of the present invention can also improve blood lipids, reduce liver fat accumulation, and inhibit the development of liver inflammation. The compound or composition of the present invention can be used to prevent and / or treat metabolic disorders and related complications. The compound or composition of the present invention can be used to treat bone diseases related to endocrine diseases, metabolic disorders, kidney disease, etc., such as osteoporosis and osteoarthritis.

The present invention relates to the use of an s100a8 / a9 and complement 3 inhibitor in the preparation of a drug for treating or preventing cachexia. The treatment or prevention of cachexia comprises increasing the body weight, lean body mass and fat mass, and increasing food intake in a cachectic subject, or preventing fat mass consumption, slowing the rate of body weight loss, the rate of fat mass loss and the rate of lean body mass loss, counteracting anorexia, muscle strength loss, fatigue and body weight loss, or improving abnormal biochemical results. Provided is a new understanding for the mechanism of energy balance regulation in cancer cachexia, with an emphasis on the effects of S100a8 / a9 and C3 in cancer cachexia. The inhibition of S100a8 / a9 and complement 3 can promote fat recovery and increase food intake. Particularly, it is verified that an S100a8 / a9 inhibitor can prevent body weight loss, especially adipose tissue loss, in a cachectic subject, and significantly increases food intake in the subject.

The utility model discloses nutrition matching tableware with a quantitative matching function, which belongs to the technical field of tableware processing and comprises a meal box, a box cover is hinged to the top surface of the meal box through a hinge, the meal box and the box cover are clamped through a lock catch, and an adjusting structure for quantitative matching is movably mounted in the meal box. The dinner plate is divided into the dish groove, the staple food groove and the porridge and soup groove so that different types of food can be clearly separated, the sanitation and freshness of the food can be kept, cross contamination possibly caused by food mixing can be reduced, the adjusting structure is arranged, and therefore the food can be conveniently and rapidly heated, and the service life of the dinner plate can be prolonged. The adjusting plate is flexibly controlled to drive the adjusting box to move along the sawtooth plate, the inner depth of the dinner plate is effectively changed, personalized catering is achieved, the food intake is accurately controlled, the inner capacity of the dinner plate is further changed in cooperation with the movable partition plate, the food amount of each meal is strictly controlled, and the body burden of a patient is prevented from being aggravated due to excessive food intake.

The application provides application of a Baoji oral liquid composition in preparation of a functional dyspepsia medicine, and relates to the technical field of medicines. The application is based on the Baoji oral liquid, and it is found that the Baoji oral liquid has a remarkable effect on treating functional dyspepsia, especially cisplatin-induced functional dyspepsia. Specifically, the Baoji oral liquid can rapidly restore body weight, significantly improve body weight gain, steadily promote food intake, significantly improve gastric emptying rate and intestinal propulsion rate, protect the gastric mucosa layer, reduce inflammatory cell infiltration, repair the mucosa layer and muscle layer, improve the expression of serum gastrin and motilin, and improve the expression level of IL-4 in the gastric tissue and reduce the expression level of IL-1beta. The Baoji oral liquid has remarkable efficacy when applied in preparation of a functional dyspepsia medicine.

The objective is to provide a diversity assessment device, a diversity assessment method, and a diversity assessment program that can assess food diversity while considering nutrient diversity by evaluating the diversity of ingested foods based on clusters that classify foods. [Solution] Based on food component data, a food classification is set by classifying the target specified foods according to nutrients using a clustering method, data on the intake status of specified foods included in a meal classified according to the food classification is obtained, and a dietary diversity score is calculated for the specified food intake status data.

The invention belongs to the technical field of biological medicines, and particularly relates to a composite active polypeptide composition with a weight losing effect and a preparation method thereof. The composite active polypeptide composition comprises NT analogue polypeptide ELP3, mulberry leaf polypeptide, balsam pear polypeptide, sea cucumber polypeptide and oyster peptide; the amino acid sequence of the NT analogue polypeptide ELP3 is as shown in SEQ ID NO. 1. According to the present invention, the artificial peptide fragment AYYKSQWLVNGEGTP is added to the end of the wild type NT, such that the gastric acid secretion can be inhibited, and the activity of the alpha-amylase can be significantly inhibited; the NT analogue polypeptide ELP3 and various polypeptide components are matched to achieve a synergistic effect, so that the blood fat metabolism condition of obese mice can be effectively improved, and the fat weight of the mice is reduced; meanwhile, the food intake of the mice can be remarkably inhibited, so that the purpose of reducing the weight of the mice is achieved, and a good weight-losing effect is achieved.